Patents by Inventor Ulf Ellervik

Ulf Ellervik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Glucono delta-lactone for treatment of vaginal fungal infections
    Patent number: 11696891
    Abstract: The present invention relates to a pharmaceutical formulation for vaginal administration, wherein the formulation comprises a pharmaceutical acceptable excipient and glucono ?-lactone, wherein the glucono ?-lactone is present in an amount of 5 to 99 wt % of the formulation. The invention also relates to a pharmaceutical formulation according to the invention for use in the prevention or treatment of a urogenital fungal infection. Furthermore, the invention relates to glucono ?-lactone (formula (III)), for use in the in the prevention or treatment of a fungal infection.
    Type: Grant
    Filed: March 31, 2021
    Date of Patent: July 11, 2023
    Assignee: Gedea Biotech AB
    Inventors: Ulf Ellervik, Olov Sterner, Helena Strevens, Sophie Manner
  • GLUCONIC ACID DERIVATIVES FOR USE IN THE TREATMENT AND/OR PREVENTION OF MICROBIAL INFECTIONS
    Publication number: 20230181523
    Abstract: Pharmaceutical compositions and methods of using said pharmaceutical compositions are provided herein. A method of preventing preterm birth in a pregnant individual is also provided, said method comprising administering to said individual a pharmaceutical composition comprising a compound of Formula XX or a lactone thereof of formula XIX or XXI and preventing said preterm birth by said administration.
    Type: Application
    Filed: February 2, 2023
    Publication date: June 15, 2023
    Applicant: GEDEA BIOTECH AB
    Inventors: Ulf ELLERVIK, Olov STERNER, Helena STREVENS, Sophie MANNER
  • Gluconic acid derivatives for use in the treatment and/or prevention of microbial infections
    Patent number: 11612584
    Abstract: The present invention concerns a pharmaceutical composition comprising a compound of Formula I for use in the treatment and/or prevention of microbial infections. Furthermore, the present invention concerns a method for prevention and/or reduction of biofilm formation.
    Type: Grant
    Filed: October 5, 2018
    Date of Patent: March 28, 2023
    Assignee: Gedea Biotech AB
    Inventors: Ulf Ellervik, Olov Sterner, Helena Strevens, Sophie Manner
  • Vaginal Tablet Formulation
    Publication number: 20220193031
    Abstract: The present invention concerns a pharmaceutical composition comprising glucono-?-lactone, which is suitable for use in the treatment of vaginal microbial infections.
    Type: Application
    Filed: April 3, 2020
    Publication date: June 23, 2022
    Applicant: GEDEA BIOTECH AB
    Inventors: Ulf Ellervik, Sophie Manner, Olov Sterner, Helena Strevens, Nils-Olof Lindberg, Annette Säfholm
  • GLUCONO DELTA-LACTONE FOR TREATMENT OF VAGINAL FUNGAL INFECTIONS
    Publication number: 20210212937
    Abstract: The present invention relates to a pharmaceutical formulation for vaginal administration, wherein the formulation comprises a pharmaceutical acceptable excipient and glucono ?-lactone, wherein the glucono ?-lactone is present in an amount of 5 to 99 wt % of the formulation. The invention also relates to a pharmaceutical formulation according to the invention for use in the prevention or treatment of a urogenital fungal infection. Furthermore, the invention relates to glucono ?-lactone (formula (III)), for use in the in the prevention or treatment of a fungal infection.
    Type: Application
    Filed: March 31, 2021
    Publication date: July 15, 2021
    Inventors: Ulf Ellervik, Olov Sterner, Helena Strevens, Sophie Manner
  • Glucono delta-lactone for treatment of vaginal fungal infections
    Patent number: 10993907
    Abstract: The present invention relates to a pharmaceutical formulation for vaginal administration, wherein the formulation comprises a pharmaceutical acceptable excipient and glucono ?-lactone, wherein the glucono ?-lactone is present in an amount of 5 to 99 wt % of the formulation. The invention also relates to a pharmaceutical formulation according to the invention for use in the prevention or treatment of a urogenital fungal infection. Furthermore, the invention relates to glucono ?-lactone (formula (III)), for use in the in the prevention or treatment of a fungal infection.
    Type: Grant
    Filed: April 6, 2017
    Date of Patent: May 4, 2021
    Assignee: Gedea Biotech AB
    Inventors: Ulf Ellervik, Olov Sterner, Helena Strevens, Sophie Manner
  • GLUCONIC ACID DERIVATIVES FOR USE IN THE TREATMENT AND/OR PREVENTION OF MICROBIAL INFECTIONS
    Publication number: 20200253925
    Abstract: The present invention concerns a pharmaceutical composition comprising a compound of Formula I for use in the treatment and/or prevention of microbial infections. Furthermore, the present invention concerns a method for prevention and/or reduction of biofilm formation.
    Type: Application
    Filed: October 5, 2018
    Publication date: August 13, 2020
    Applicant: GEDEA BIOTECH AB
    Inventors: Ulf ELLERVIK, Olov STERNER, Helena STREVENS, Sophie MANNER
  • GLUCONO DELTA-LACTONE FOR TREATMENT OF VAGINAL FUNGAL INFECTIONS
    Publication number: 20190110983
    Abstract: The present invention relates to a pharmaceutical formulation for vaginal administration, wherein the formulation comprises a pharmaceutical acceptable excipient and glucono ?-lactone, wherein the glucono ?-lactone is present in an amount of 5 to 99 wt % of the formulation. The invention also relates to a pharmaceutical formulation according to the invention for use in the prevention or treatment of a urogenital fungal infection. Furthermore, the invention relates to glucono ?-lactone (formula (III)), for use in the in the prevention or treatment of a fungal infection.
    Type: Application
    Filed: April 6, 2017
    Publication date: April 18, 2019
    Inventors: Ulf Ellervik, Olov Sterner, Helena Strevens, Sophie Manner
  • Antiviral compounds
    Patent number: 8802654
    Abstract: Herein are disclosed novel compounds according to Formula (I) and aggregates comprising such compounds. These aggregates are useful to treat and prevent ocular infections caused by a vims, which virus binds to terminal sialic residues present on the cell surface of the cell to be infected by the virus.
    Type: Grant
    Filed: July 5, 2010
    Date of Patent: August 12, 2014
    Assignee: Adenovir Pharma AB
    Inventors: Olov Sterner, Ulf Ellervik, Karolina Aplander, Anders Carlsson
  • ANTIVIRAL COMPOUNDS
    Publication number: 20120129795
    Abstract: Herein are disclosed novel compounds according to Formula (I) and aggregates comprising such compounds. These aggregates are useful to treat and prevent ocular infections caused by a vims, which virus binds to terminal sialic residues present on the cell surface of the cell to be infected by the virus.
    Type: Application
    Filed: July 5, 2010
    Publication date: May 24, 2012
    Applicant: ADENOVIR PHARMA AB
    Inventors: Olov Sterner, Ulf Ellervik, Karolina Aplander, Anders Carlsson
  • Antiproliferative Compositions Comprising Aryl Substituted Xylopyranoside Derivatives
    Publication number: 20080027023
    Abstract: Novel xylose based glycoside compounds that have xylose linked O-, S- or C-glycosidically to an aglycone containing several aromatic rings, and compositions that comprise the novel xylose based glycosides and non-xylose-based anti-tumor agents, pharmaceuticals or dietary supplements. The compounds or compositions are administered to treat proliferative diseases, including various forms of cancer.
    Type: Application
    Filed: July 14, 2005
    Publication date: January 31, 2008
    Inventors: Ulf Ellervik, Lars-Ake Fransson, Mattias Belting, Katrin Mani